Why the study?
The predictive value of flow-mediated vasodilation compared with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging for diagnosing coronary artery disease was unclear.
Does flow-mediated vasodilation (FMD) accurately diagnose coronary artery disease in patients with chest pain syndrome compared to routine diagnostic tests?
Observational (n=92)
No
Does flow-mediated vasodilation (FMD) accurately diagnose coronary artery disease in patients with chest pain syndrome compared to routine diagnostic tests?
In patients with chest pain syndrome, FMD is a sensitive indicator of CAD with moderate specificity, though it cannot accurately predict disease extent and severity.
FMD shows moderate diagnostic accuracy for CAD in chest pain; leaves open its clinical utility versus standard tests pending larger prospective validation.
OBJECTIVE: To determine the predictive value of flow-mediated vasodilation (FMD) compared with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging (MPI). METHODS: This study was carried out in Shahid Madani Heart Center, Tabriz, Iran from April 2004 to September 2006. A total of 92 patients with chest pain syndrome were enrolled in this study. Using high resolution ultrasound system endothelial function was evaluated, and the result of the flow-mediated dilation (FMD%) was defined as the percent change in the internal diameter of the brachial artery during reactive hyperemia related to baseline. RESULTS: Coronary artery disease (CAD) was documented in 77 (83.7%) patients. The percentage of FMD was lower in patients with CAD compared with those +/- 4.61, p=0.001). In comparison with typical anginal chest pain (sensitivity 46.7%, specificity 80%), exercise stress test (sensitivity 75%, specificity 60%), and MPI (sensitivity 96.5, specificity 55.6%) the receiver operator characteristic curve showed the percentage FMD optimal cut-off value as </=7.41 with a sensitivity of 87.0%, specificity of 66.7%, negative predictive value of 93.0%, and positive predictive value of 50%. CONCLUSION: In patients with chest pain syndrome, the FMD is a sensitive indicator of CAD with moderate specificity that is unable to predict accurately the extent and severity of it.
No takes yet. Share an insight, caveat, or question.
Ghaffari et al. (2007) conducted an observational in Chest pain syndrome (n=92). Flow-mediated vasodilation (FMD) vs. Routine diagnostic tests (angina pectoris, exercise ECG, MPI) was evaluated on Diagnosis of coronary artery disease (p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: